VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OPCHOption Care Health, Inc.
$21.82$3.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksOPCHCash Flow

Option Care Health, Inc. (OPCH) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow volatility remains a primary concern, with margins swinging from 15.1% in 2024Q2 to a negative 0.9% in 2026Q1, exacerbated by erratic working capital fluctuations.

OPCH Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations253.55M258.45M323.39M371.3M267.55M208.57M127.39M39.47M-20.1M-1.05M-35.2M-64.74M-31.42M-54.58M26.88M26.97M-21.42M22.75M-8.75M24.19M-29.86M-6.42M3.29M14.34M20.8M10.93M11.33M12.9M-16.4M-3.1M-7.6M
Operating CF Margin %-4.57%6.47%8.63%6.78%6.07%4.2%1.71%-1.04%-0.13%-3.76%-6.59%-3.4%-7.84%4.53%4.86%-4.97%1.71%-0.62%2.02%-2.59%-0.6%0.52%2.44%3.61%2.39%3.35%3.68%-3.64%-1.28%-2.68%
Operating CF Growth %-135.41%-20.08%-12.9%38.78%28.28%63.72%222.78%296.31%-1811.03%97.01%45.63%-106.08%42.44%-303.02%-0.32%225.91%-194.17%360.06%-136.16%181%-365%-294.96%-77.03%-31.05%90.38%-3.6%-12.11%178.63%-429.03%59.21%-
Net Income206.19M207.59M211.82M267.09M150.56M139.9M-8.08M-75.92M-51.59M-61.28M-34.37M-303.43M-143.38M-53.61M-8.34M7.87M-69.14M54.1M-74.03M3.32M-38.29M-23.85M7.03M9.13M18.68M14.2M-1.82M-3.79M4.3M-13.5M-31.8M
Depreciation & Amortization69.97M70.69M63.5M62.2M65.43M68.8M77.9M57.87M23.6M26.31M21.55M22.74M22.94M20.23M12.47M15.88M12.33M5.03M6.39M7.09M10.85M35.08M5.02M5.08M6.06M6.36M4.88M3.22M1.7M1.1M800K
Stock-Based Compensation-232K39.96M36.14M30.48M16.78M9.57M2.92M4.17M4.17M2.36M1.96M4.51M8.57M9.45M6.12M4.47M3.32M3.42M3.79M000000000000
Deferred Taxes08.44M12.66M12.77M49.19M-30.37M1.2M-4.61M66K-3.15M2.04M-20.09M12.32M4.82M-4K1.16M47.34M-40.52M-12.22M2.81M20.3M-6.03M000000000
Other Non-Cash Items-10.6M31.52M19.52M20.2M15.36M32.03M46.33M19.38M20.35M17.01M-14.96M252.81M-7.61M-3M-21.56M1.46M11.72M8.52M98.55M8.12M15.43M13.87M2M2M487K-1.06M2.9M6.54M-100K500K27.6M
Working Capital Changes-11.78M-99.75M-20.25M-21.45M-29.78M-11.37M7.13M38.58M-16.71M17.71M-11.44M-21.29M75.74M-32.46M38.2M-3.86M-26.99M-7.8M-31.23M2.85M-38.39M-25.49M-10.76M-1.87M-4.43M-8.57M5.38M6.92M-22.4M8.8M-4.2M
Change in Receivables-40.67M-54.59M-32.08M224K-36.89M-4.27M-3.92M82.28M-29.34M23.56M-2.5M16.45M30.65M-31.86M101.23M-83.67M-69.05M-90.45M0000000000000
Change in Inventory-47.8M-81.47M-114.13M-51M-41.01M-22.7M-42.73M-12.85M11.36M-1.77M10.02M-5.77M-2.95M4.94M-15.25M9.78M-11.02M-6.03M-11.63M-127K-7.11M-3.56M-2.56M767K-2.04M-1.11M-1.01M410K-400K00
Change in Payables14.38M19.52M183.4M47.7M98.89M-10.38M59.22M-30.86M1.06M-2.54M-20.52M-24.13M26.02M22.14M-48.2M-1.66M2.94M-2.4M0000000000000
Cash from Investing-43.71M-161.08M-36.47M-56.51M-108.05M-111.54M-26.33M-727.83M-13.52M-13.34M-72.98M13.02M44.26M-302.34M93.88M-9.91M-108.55M-5.74M-7.46M-5.53M-18.41M3.12M-17.08M-981K-33.27M-3.65M-22.56M2.57M7.8M10.9M-38.9M
Capital Expenditures-9.1M-41.31M0-41.87M-35.36M-25.63M-26.88M-28.29M-13.88M-8.39M-9.64M-11.54M-13.83M-25.62M-10.99M-9.44M-11.11M-5.74M-7.46M-5.53M-5.44M-5.13M-1.06M-961K-2.1M-2.63M-6.63M-2.18M-2.2M-1.6M-900K
CapEx % of Revenue0.16%0.73%0.71%0.97%0.9%0.75%0.89%1.22%0.72%1.03%1.03%1.18%1.5%3.68%1.85%1.7%2.58%0.43%0.53%0.46%0.47%0.48%0.17%0.16%0.36%0.58%1.96%0.62%0.49%0.66%0.32%
Acquisitions75K-117.25M0-12.49M-87.36M-85.91M0-700.17M360K0-63.34M0398K-274.36M-13.59M00000-13.1M0-14.26M0-34.85M-2.19M-19.64M0000
Investments-------------------------------
Other Investing-34.69M-2.53M-36.47M-2.15M14.67M0541K636K360K-4.95M-63.34M24.57M56.84M-2.36M118.45M-463K-97.43M000125K8.25M-1.76M-20K3.69M1.16M-1.32M-1.91M-900K400K-1M
Cash from Financing-203.89M-277.31M-218.21M-265.13M15.27M-76.87M-68.85M719.02M8.07M44.28M109.74M66.56M-13.1M295.82M-58.66M-17.06M129.97M-17.01M16.21M-18.66M46.75M1.86M7.31M-9.69M5.73M3.92M-2.79M-4.65M3.5M-100K46.5M
Debt Issued (Net)49.16M40.9M43.58M-6M-6M-76.84M-183.25M752.24M-4.15M23.38M26.68M9.61M-14.2M174.89M-67.1M-20.07M126.98M-20.02M16.63M-19.13M45.37M89K6.44M-5.24M4.05M-753K-3.12M-4.32M3.5M-200K-300K
Equity Issued (Net)-209.73M-309.95M-252.73M-250.26M0-32K118.93M0020.78M83.27M59.69M0118.38M003.99M3.02M-424K1.87M01.78M876K-4.45M1.68M4.68M333K-333K0100K46.8M
Dividends Paid0000000-2M00000000000000000000000
Share Repurchases-227.27M-309.95M-252.73M-250.26M0-32K0-2.5M00000000-128K-119K-889K-1.4M000-5.07M0-2.6M0-338K000
Other Financing-43.33M-8.25M-9.05M-8.87M21.27M0-4.53M-31.21M0120K-202K-2.74M1.1M2.55M8.44M3.01M-1M1K0-1.4M1.38M0000000000
Net Change in Cash5.95M-179.94M68.72M49.66M174.76M20.16M32.21M30.66M-25.55M29.89M-6.01M14.84M-261K-61.1M-58.66M0000046.75M-1.44M-6.47M3.68M-6.74M11.2M-14.02M10.81M3.5M-100K0
Free Cash Flow244.46M258.45M287.79M329.43M232.19M182.94M100.52M11.18M-33.98M-9.44M-44.84M-76.29M-45.24M-80.2M15.9M17.52M-32.53M17.01M-16.21M18.66M-35.3M-11.55M2.24M13.38M18.7M8.29M4.7M10.72M-18.6M-4.7M-8.5M
FCF Margin %4.31%4.57%5.76%7.66%5.89%5.32%3.31%0.48%-1.75%-1.16%-4.79%-7.77%-4.9%-11.51%2.68%3.16%-7.55%1.28%-1.16%1.56%-3.06%-1.08%0.35%2.27%3.24%1.82%1.39%3.06%-4.12%-1.94%-3%
FCF Growth %-29.31%-10.19%-12.64%41.88%26.92%82%799.48%132.89%-259.87%78.95%41.21%-68.61%43.58%-604.44%-9.28%153.87%-291.3%204.92%-186.86%152.87%-205.58%-616.59%-83.29%-28.44%125.46%76.47%-56.14%157.61%-295.74%44.71%-
FCF per Share1.551.581.661.831.281.010.560.07-1.06-0.31-1.91-4.44-2.64-4.971.131.29-2.581.71-1.691.94-3.78-1.350.392.363.171.500.932.26-4.50-1.49-3.56
FCF Conversion (FCF/Net Income)1.19x1.25x1.53x1.39x1.78x1.49x-15.77x-0.52x3.29x0.02x0.82x0.22x0.21x0.78x0.42x3.43x0.31x0.42x0.12x7.29x0.78x0.27x0.47x1.57x1.11x0.77x-6.22x-3.41x-3.81x0.23x0.24x
Interest Paid21.76M071.55M69.8M50.37M60.92M97.64M50.81M47.17M45.38M34.7M34.3M-34.13M25.59M27.53M27.53M20.12M1.92M4.01M000000000000
Taxes Paid38.6M064.52M75.24M13.44M5.71M2.88M2.4M1.6M649K372K114K-1.65M3.14M1.04M1.04M2.56M741K382K000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Lacks Cash Support

As reported in recent financial statements, Option Care Health's OCF/NI ratio has fluctuated wildly, reaching a negative 0.27 in 2026Q1, which suggests that reported net income is frequently decoupled from actual cash generation due to the inherent complexities of the buy-and-bill reimbursement model.

The significant divergence between net income and operating cash flow indicates that accounting profits are heavily reliant on non-cash accruals and timing differences in insurance collections. Investors should monitor whether this disconnect reflects structural delays in reimbursement or an inability to convert service delivery into timely cash inflows.

Free Cash Flow Volatility Persists

Based on the company's reported figures, free cash flow margins have swung from a peak of 15.1% in 2024Q2 to a negative 0.9% in 2026Q1, illustrating a highly inconsistent ability to generate surplus cash after accounting for necessary capital expenditures and working capital requirements.

This erratic trajectory suggests that the business model is highly sensitive to operational disruptions and working capital cycles. The inability to maintain positive free cash flow in recent periods raises questions about the sustainability of the company's current capital allocation strategy.

Working Capital Swings Obscure Performance

According to recent SEC filings, working capital changes have been a primary driver of cash flow volatility, with swings as large as negative $150 million in 2024Q1, indicating that the company's cash position is highly vulnerable to the timing of payor reimbursements and inventory management.

The extreme variance in working capital suggests that the company lacks a stable cash conversion cycle, likely due to the administrative burden of managing complex insurance claims. This volatility makes it difficult to forecast underlying cash generation and may mask underlying operational inefficiencies.

Aggressive Buybacks Amidst Cash Strain

As evidenced by financial data, the company has consistently prioritized share repurchases, including $95.1 million in 2025Q4, even during periods of negative operating cash flow, which suggests a capital allocation strategy that may be disconnected from the reality of its internal cash generation capabilities.

Prioritizing shareholder returns while operating cash flow remains inconsistent warrants further investigation into the company's long-term liquidity planning. This approach may limit the financial flexibility required to navigate potential reimbursement headwinds or future operational investments.

SBC and Capitalization Mask Realities

Based on reported figures, the company's cash flow statement is frequently impacted by stock-based compensation adjustments and acquisition-related outflows, which complicate the assessment of true recurring cash generation and suggest that headline figures may overstate the company's underlying financial health.

The reliance on non-cash adjustments to bolster reported metrics may obscure the true cost of operations and the impact of past M&A activity. Analysts should be cautious of these adjustments, as they may hide the true cash impact of maintaining the company's specialized clinical workforce.

OPCH — Frequently Asked Questions

Quick answers to the most common questions about buying OPCH stock.

How much cash does Option Care Health, Inc. (OPCH) generate from operations?

Option Care Health, Inc. (OPCH) generated $258.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Option Care Health, Inc.'s free cash flow?

Option Care Health, Inc. (OPCH) generated $258.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Option Care Health, Inc.'s capital expenditure (CapEx)?

Option Care Health, Inc. (OPCH) spent $41.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Option Care Health, Inc. distribute cash to shareholders?

In 2025, Option Care Health, Inc. (OPCH) spent $310.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.